NewsBenzinga일요일 보도, 존슨앤드존슨, 파스리타미그 및 JNJ-9401이 1상 전립선암 연구에서 73% PSA 반응률 달성 및 3등급 이상 치료 관련 이상반응 미발생, 외래 환자 투여 지원 일요일 보도, 존슨앤드존슨, 파스리타미그 및 JNJ-9401이 1상 전립선암 연구에서 73% PSA 반응률 달성 및 3등급 이상 치료 관련 이상반응 미발생, 외래 환자 투여 지원 Benzinga 2026.11.09 08:10 (GMT+0) Open on Benzinga Other news Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report How To Earn $500 A Month From Target Stock Ahead Of Q3 Earnings Stifel Reinstates Buy on Walmart, Announces $145 Price Target HC Wainwright & Co. Reiterates Buy on Perpetua Resources, Maintains $43.5 Price Target Stifel Reinstates Hold on Target, Announces $155 Price Target WW International Intends To Utilize Up To $10M In Cash To Prepay Portion Of Outstanding Term Loan At Discount Through Voluntary Solicitation Of Offers From Term Loan Lenders
Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report
WW International Intends To Utilize Up To $10M In Cash To Prepay Portion Of Outstanding Term Loan At Discount Through Voluntary Solicitation Of Offers From Term Loan Lenders